Possible utilization of extracorporeal immunoadsorption and other immunologic methods in the treatment of schizophrenia.
D000818:Animals; D000906:Antibodies / Q000008:administration & dosage; D001812:Blood-Brain Barrier; D001921:Brain / Q000276:immunology; D000939:Epitopes; D006801:Humans; D007163:Immunosorbent Techniques; D009419:Nerve Tissue Proteins / Q000276:immunology; D011950:Receptors, Cholinergic / Q000276:immunology; D011954:Receptors, Dopamine / Q000276:immunology; D012559:Schizophrenia / Q000209:etiology / Q000276:immunology / Q000628:therapy*
D000906:Antibodies; D000939:Epitopes; D009419:Nerve Tissue Proteins; D011950:Receptors, Cholinergic; D011954:Receptors, Dopamine